2007
We recommend that the Partnership funds two large partnered projects: (1) the Canadian Partnership for Tomorrow Project (CPTP) of 330 000 volunteers from five Canadian regions to give perspective on chronic diseases, and (2) a translational research initiative, designed to establish a roadmap for biomarker development across Canada. [CPTP is now CanPath, the Canadian Partnership for Tomorrow’s Health.]
The CCRA joins the International Cancer Research Partnership (ICRP), an alliance of cancer organizations enhancing global collaboration and strategic coordination of research.
We release our first cancer research investment report about investments made in 2005 by 19 funding organizations. The report garners front-page coverage in The Globe and Mail and Dr. Philip Branton is invited by The Lancet Oncology to comment on the findings.
New CCRA Advisory Board Leadership
Effective January 1st, 2024, CCRA welcomes new CCRA Advisory Board chair, Dr. Dajan O’Donnell. Dajan is the Director of Scientific Affairs and Partnerships at the Cancer Research Society (CRS) and has work... Read More »
Effective January 1st, 2024, CCRA welcomes new CCRA Advisory Board chair, Dr. Dajan O’Donnell. Dajan is the Director of Scientific Affairs and Partnerships at the Cancer Research Society (CRS) and has work... Read More »
New Member to the CCRA Advisory Board
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a P... Read More »
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a P... Read More »